Delivery Order SPE2DB20D1100-SPE2DB24FA9J9
Award Date
3/26/24
Potential Completion Date
3/27/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GLATIRAMER 40 MG/ML SYRINGE medications. The contract has a completion date of February 16, 2024 and a potential value of $2,832.12. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the pharmaceutical products to DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of glatiramer 40 mg/mL syringes, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,888.11 and a period of performance through April 23, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,687.43 Firm Fixed Price delivery order is for the supply of Glatiramer 40 mg/mL syringes, with a completion date of March 4, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the supply of Glatopa 40 mg/ml syringes, a specialty medication, with a ceiling value of $8,388.16. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of November 14, 2023. This contract award is associated with a larger Indefinite Delivery Contract...
The Defense Logistics Agency awarded a $3,666.66 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562084498, Glatiramer 40 mg/ml syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 8, 2023 under a firm fixed price arrangement. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to support military readiness by...
The Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $1,069.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of COPAXONE 40 MG/ML syringes. The contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a Firm Fixed Price Delivery Order for the supply of COPAXONE 40 MG/ML syringes. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...